참고문헌
- Aitken, A. (1996). 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol. 6, 341-347. https://doi.org/10.1016/0962-8924(96)10029-5
- Bettendorf, O., Piffko, J., and Bankfalvi, A. (2004). Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol. 40, 110-119. https://doi.org/10.1016/j.oraloncology.2003.08.010
- Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., and Darnell, J.E., Jr. (1999). Stat3 as an oncogene. Cell 98, 295-303. https://doi.org/10.1016/S0092-8674(00)81959-5
- Butt, A.Q., Ahmed, S., Maratha, A., and Miggin, S.M. (2012). 14-3- 3epsilon and 14-3-3sigma inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction. J. Biol. Chem. 287, 38665-38679. https://doi.org/10.1074/jbc.M112.367490
- Choi, J.E., Hur, W., Jung, C.K., Piao, L.S., Lyoo, K., Hong, S.W., Kim, S.W., Yoon, H.Y., and Yoon, S.K. (2011). Silencing of 14- 3-3zeta over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium. Cancer Lett. 303, 99-107. https://doi.org/10.1016/j.canlet.2011.01.015
- Danes, C.G., Wyszomierski, S.L., Lu, J., Neal, C.L., Yang, W., and Yu, D. (2008). 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res. 68, 1760-1767. https://doi.org/10.1158/0008-5472.CAN-07-3177
- Dhillon, A.S., Yip, Y.Y., Grindlay, G.J., Pakay, J.L., Dangers, M., Hillmann, M., Clark, W., Pitt, A., Mischak, H., and Kolch, W. (2009). The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switch. Cell. Signal. 21, 1645-1651. https://doi.org/10.1016/j.cellsig.2009.07.001
- Faisal, A., Saurin, A., Gregory, B., Foxwell, B., and Parker, P.J. (2008). The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors. J. Biol. Chem. 283, 18591-18600. https://doi.org/10.1074/jbc.M710330200
- Fanger, G.R., Widmann, C., Porter, A.C., Sather, S., Johnson, G.L., and Vaillancourt, R.R. (1998). 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 273, 3476-3483. https://doi.org/10.1074/jbc.273.6.3476
- Hashiguchi, M., Sobue, K., and Paudel, H.K. (2000). 14-3-3zeta is an effector of tau protein phosphorylation. J. Biol. Chem. 275, 25247-25254. https://doi.org/10.1074/jbc.M003738200
- He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514. https://doi.org/10.1073/pnas.95.5.2509
- Ichimura, T., Isobe, T., Okuyama, T., Takahashi, N., Araki, K., Kuwano, R., and Takahashi, Y. (1988). Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinasedependent activator of tyrosine and tryptophan hydroxylases. Proc. Natl. Acad. Sci. USA 85, 7084-7088. https://doi.org/10.1073/pnas.85.19.7084
- Jang, J.S., Cho, H.Y., Lee, Y.J., Ha, W.S., and Kim, H.W. (2004). The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol. Res. 14, 491-499. https://doi.org/10.3727/0965040042380441
- Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90. https://doi.org/10.3322/caac.20107
- Kwak, B., Mulhaupt, F., Myit, S., and Mach, F. (2000). Statins as a newly recognized type of immunomodulator. Nat Med. 6, 1399-1402. https://doi.org/10.1038/82219
- Lakshmi Narendra, B., Eshvendar Reddy, K., Shantikumar, S., and Ramakrishna, S. (2013). Immune system: a double-edged sword in cancer. Inflamm. Res. 62, 823-834. https://doi.org/10.1007/s00011-013-0645-9
- Leeman, R.J., Lui, V.W., and Grandis, J.R. (2006). STAT3 as a therapeutic target in head and neck cancer. Expert Opin. Biol. Ther. 6, 231-241. https://doi.org/10.1517/14712598.6.3.231
- Levy, D.E., and Darnell, J.E., Jr. (2002). Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651-662. https://doi.org/10.1038/nrm909
- Li, Z., Zhao, J., Du, Y., Park, H.R., Sun, S.Y., Bernal-Mizrachi, L., Aitken, A., Khuri, F.R., and Fu, H. (2008). Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc. Natl. Acad. Sci. USA 105, 162-167. https://doi.org/10.1073/pnas.0710905105
- Lin, M., Morrison, C.D., Jones, S., Mohamed, N., Bacher, J., and Plass, C. (2009). Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int. J. Cancer 125, 603-611. https://doi.org/10.1002/ijc.24346
- Matta, A., Bahadur, S., Duggal, R., Gupta, S.D., and Ralhan, R. (2007). Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer 7, 169. https://doi.org/10.1186/1471-2407-7-169
- Min, B.M., Lee, G., Kim, S.H., Nam, Y.S., Lee, T.S., and Park, W.H. (2004). Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 25, 1289-1297. https://doi.org/10.1016/j.biomaterials.2003.08.045
- Neal, C.L., and Yu, D. (2010). 14-3-3zeta as a prognostic marker and therapeutic target for cancer. Expert Opin. Ther. Targets 14, 1343-1354. https://doi.org/10.1517/14728222.2010.531011
- Neal, C.L., Yao, J., Yang, W., Zhou, X., Nguyen, N.T., Lu, J., Danes, C.G., Guo, H., Lan, K.H., Ensor, J., et al. (2009). 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res. 69, 3425-3432. https://doi.org/10.1158/0008-5472.CAN-08-2765
- Neal, C.L., Xu, J., Li, P., Mori, S., Yang, J., Neal, N.N., Zhou, X., Wyszomierski, S.L., and Yu, D. (2012). Overexpression of 14-3- 3zeta in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene 31, 897-906. https://doi.org/10.1038/onc.2011.284
- O'Shea, J.J., Holland, S.M., and Staudt, L.M. (2013). JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 368, 161-170. https://doi.org/10.1056/NEJMra1202117
- Ochsenbein, A.F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., and Zinkernagel, R.M. (2001). Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411, 1058-1064. https://doi.org/10.1038/35082583
- Parkin, D.M., Pisani, P., and Ferlay, J. (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80, 827-841. https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
- Reuther, G.W., and Pendergast, A.M. (1996). The roles of 14-3-3 proteins in signal transduction. Vitam. Horm. 52, 149-175. https://doi.org/10.1016/S0083-6729(08)60410-0
- Saurin, A.T., Durgan, J., Cameron, A.J., Faisal, A., Marber, M.S., and Parker, P.J. (2008). The regulated assembly of a PKCepsilon complex controls the completion of cytokinesis. Nat. Cell Biol. 10, 891-901. https://doi.org/10.1038/ncb1749
- Schuster, T.B., Costina, V., Findeisen, P., Neumaier, M., and Ahmad- Nejad, P. (2011). Identification and functional characterization of 14-3-3 in TLR2 signaling. J. Proteome Res. 10, 4661-4670. https://doi.org/10.1021/pr200461p
- Silver, D.L., Naora, H., Liu, J., Cheng, W., and Montell, D.J. (2004). Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res. 64, 3550-3558. https://doi.org/10.1158/0008-5472.CAN-03-3959
- Sriuranpong, V., Park, J.I., Amornphimoltham, P., Patel, V., Nelkin, B.D., and Gutkind, J.S. (2003). Epidermal growth factor receptorindependent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 63, 2948-2956.
- Sun, L., Stoecklin, G., Van Way, S., Hinkovska-Galcheva, V., Guo, R.F., Anderson, P., and Shanley, T.P. (2007). Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J. Biol. Chem. 282, 3766-3777.
- Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004). Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10, 48-54. https://doi.org/10.1038/nm976
- Wang, M.L., Shin, M.E., Knight, P.A., Artis, D., Silberg, D.G., Suh, E., and Wu, G.D. (2005). Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine. Am. J. Physiol. Gastrointest Liver Physiol. 288, G1074-1083. https://doi.org/10.1152/ajpgi.00442.2004
- Wang, B., Liu, K., Lin, H.Y., Bellam, N., Ling, S., and Lin, W.C. (2010). 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol. Cell. Biol. 30, 1508-1527. https://doi.org/10.1128/MCB.01335-09
- Wang, X., Crowe, P.J., Goldstein, D., and Yang, J.L. (2012). STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int. J. Oncol. 41, 1181-1191. https://doi.org/10.3892/ijo.2012.1568
- Wei, D., Le, X., Zheng, L., Wang, L., Frey, J.A., Gao, A.C., Peng, Z., Huang, S., Xiong, H.Q., Abbruzzese, J.L., et al. (2003). Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22, 319-329. https://doi.org/10.1038/sj.onc.1206122
- Yaffe, M.B., Rittinger, K., Volinia, S., Caron, P.R., Aitken, A., Leffers, H., Gamblin, S.J., Smerdon, S.J., and Cantley, L.C. (1997). The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961-971. https://doi.org/10.1016/S0092-8674(00)80487-0
- Yang, X., Cao, W., Zhang, L., Zhang, W., Zhang, X., and Lin, H. (2012). Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther. 19, 153-159. https://doi.org/10.1038/cgt.2011.85
- Yu, H., Kortylewski, M., and Pardoll, D. (2007). Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41-51. https://doi.org/10.1038/nri1995
- Zhang, J., Chen, F., Li, W., Xiong, Q., Yang, M., Zheng, P., Li, C., Pei, J., and Ge, F. (2012). 14-3-3zeta interacts with stat3 and regulates its constitutive activation in multiple myeloma cells. PLoS One 7, e29554. https://doi.org/10.1371/journal.pone.0029554
피인용 문헌
- A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in or vol.11, pp.12, 2015, https://doi.org/10.1039/c5mb00468c
- Proliferative effects of gamma-amino butyric acid on oral squamous cell carcinoma cells are associated with mitogen-activated protein kinase signaling pathways vol.38, pp.1, 2015, https://doi.org/10.3892/ijmm.2016.2597
- The clinical and prognostic significance of YWHAZ in non‐small–cell lung cancer patients: Immunohistochemical analysis vol.120, pp.4, 2019, https://doi.org/10.1002/jcb.27915
- The SARS-CoV-2 RNA–protein interactome in infected human cells vol.6, pp.3, 2021, https://doi.org/10.1038/s41564-020-00846-z